Serale Bio Pharma Private Limited - Company Profile

It is a business services private limited company based in Chennai, Tamil Nadu, India, established in 2012.
2012 Chennai, Tamil Nadu, India Struck Off
Last Updated:
Access Report
About Serale Bio Pharma Private Limited

Serale Bio Pharma Private Limited, a struck off private limited company, was established on 22 December 2012 in Chennai, Tamil Nadu, India. Engaging in miscellaneous business activities within the business services sector, it holds CIN: U74900TN2012PTC089121. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Iyyakutty Vellaiammal (Director), Suhasini Seralathan (Director), Thulasi Seralathan (Managing Director). It is based at No.19A-3,Thirumalai Nagar, Valasaravakkam., Chennai, Tamil Nadu, 600087.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74900TN2012PTC089121

  • Registration Number

    089121

  • Incorporation Date

    22 December 2012

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Chennai

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 13 Year, 4 Months
Company report

Serale Bio Pharma Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Serale Bio Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Serale Bio Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Iyyakutty Vellaiammal Director 22 Dec 2012 Current
Suhasini Seralathan Director 22 Dec 2012 Current
Thulasi Seralathan Managing Director 22 Dec 2012 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Serale Bio Pharma.

Enhance accessibility to Serale Bio Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Serale Bio Pharma revenue growth over time
Serale Bio Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Serale Bio Pharma?

Unlock access to Serale Bio Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Serale Bio Pharma?

Unlock and access historical data on people associated with Serale Bio Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Serale Bio Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Serale Bio Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Serale Bio Pharma
Recent Activity within the Organization
  • Director Appointment

    The activity Iyyakutty Vellaiammal was appointed as a Director was appointed as a Director on 22 Dec 2012 & has been associated with this company since 13 years 4 months . was completed.

  • Director Appointment

    Progress on Suhasini Seralathan was appointed as a Director was appointed as a Director on 22 Dec 2012 & has been associated with this company since 13 years 4 months . was documented.

  • Director Appointment

    Progress on Thulasi Seralathan was appointed as a Managing Director was appointed as a Managing Director on 22 Dec 2012 & has been associated with this company since 13 years 4 months . was documented.

  • Company Incorporation

    The activity Serale Bio Pharma Private Limited was registered on 22 Dec 2012 with Roc Chennai & aged 13 years 4 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Serale Bio Pharma Private Limited?

The CIN of Serale Bio Pharma Private Limited is U74900TN2012PTC089121.

Where is Serale Bio Pharma Private Limited headquartered?

Serale Bio Pharma Private Limited is headquartered at No.19A-3,Thirumalai Nagar, Valasaravakkam., Chennai, Tamil Nadu, 600087.

When was Serale Bio Pharma Private Limited incorporated?

Serale Bio Pharma Private Limited was incorporated on 22 December 2012.

Who are the current directors of Serale Bio Pharma Private Limited?

The current directors of Serale Bio Pharma Private Limited are

What is the primary industry of Serale Bio Pharma Private Limited?

The primary industry of Serale Bio Pharma Private Limited is Business Services.

Is Serale Bio Pharma Private Limited a listed company?

Serale Bio Pharma Private Limited is unlisted.

What is the capital structure of Serale Bio Pharma Private Limited?

The authorized capital of Serale Bio Pharma Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available